Survivorship care in Canadian genitourinary oncology: Toward a multidisciplinary perspective.

Authors

null

Sue Richter

Princess Margaret Hospital, Toronto, ON, Canada

Sue Richter , Ashraf AlMatar , Nafisha Lalani , Jackie Bender , David Wiljer , Laura Legere , Christine Massey , Nour Alkazaz , Majula Maganti , Pamela Catton , Srikala S. Sridhar , Michael A. Jewett

Organizations

Princess Margaret Hospital, Toronto, ON, Canada, University of Toronto, Toronto, ON, Canada, Princess Margaret Hospital/University Health Network, Toronto, ON, Canada, Cancer Survivorship Centre, Princess Margaret Hospital, Toronto, ON, Canada, University Health Network, Princess Margaret Hospital, Toronto, ON, Canada

Research Funding

No funding sources reported

Background: Genitourinary (GU) cancer survivors comprise nearly 25% of cancer survivors and >50% of all male survivors. To further improve care of this patient population, we need to better understand physician specialist perceptions of survivorship care. Methods: All medical oncologists, urologists and radiation oncologists treating GU cancers in Canada were surveyed with a web−based questionnaire. A total of 27 multiple choice and Likert scale questions were developed in 5 domains: i) demographics, ii) current post cancer treatment care practices, iii) perceived barriers, iv) accessibility to survivorship resources and v) perceptions of advocacy groups. Participants were identified through their respective professional associations. Results: There were 306 responses and 260 were eligible for analysis; 45 medical oncologists, 125 urologists and 90 radiation oncologists. A total of 56% of physicians discharged GU cancer survivor follow-up care to a primary care practitioner (PCP) at some point after treatment. Compared to urologists and radiation oncologists, medical oncologists were least likely to share care with a PCP (4%). Only 47% of all physicians consistently provided a written follow up plan to the PCP and only 25% of these provided lifeclass recommendations. Lack of time and resources were the most commonly reported barriers. About half of physicians reported access to cancer rehabilitation programs as difficult and British Columbia was the most frequently cited region without access. Medical oncologists compared to other subspecialties accessed genetic counseling more easily while access to pain management programs was cited as the most difficult. In general, physicians in community hospitals had the most difficulties. Utilization of advocacy groups was limited, e.g. 23% for prostate cancer. The most underutilized advocacy group was for testis cancer (4%). Conclusions: To our knowledge this is the first study to address the challenges of GU cancer survivorship care in Canada. The barriers to care and underutilization of advocacy groups quoted in this study may be used to stimulate nationwide initiatives to further long-term strategies in GU survivorship management planning.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Abstract Details

Meeting

2013 Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

General Poster Session B: Prostate, Penile, Urethral, and Testicular Cancer, and Urothelial Carcinoma

Track

Urothelial Carcinoma,Prostate Cancer,Penile, Urethral, and Testicular Cancer

Sub Track

Penile, Urethral, and Testicular Cancer

Citation

J Clin Oncol 31, 2013 (suppl 6; abstr 337)

DOI

10.1200/jco.2013.31.6_suppl.337

Abstract #

337

Poster Bd #

K12

Abstract Disclosures

Similar Abstracts

First Author: Ilana Yurkiewicz

Abstract

2022 ASCO Quality Care Symposium

Racial/ethnic disparities in patient care experiences among prostate cancer survivors: A SEER-CAHPS study.

First Author: Ambrish Pandit

Abstract

2023 ASCO Quality Care Symposium

Loss to primary care provider follow-up among survivors five to seven years post-diagnosis.

First Author: Alexandra G. Peluso